Published Paper Details:

The rising global prevalence of neurodegenerative diseases like Alzheimer's disease (AD) has led to the exploration of plant-based alternatives to synthetic nootropics. Embelia ribes, traditionally known for its therapeutic benefits in Ayurvedic medicine, has recently been investigated for its memory-enhancing potential. This review summarizes the pharmacological basis and preclinical findings related to E. Ribes's cognitive effects, focusing on scopolamine-induced amnesia models in Swiss albino mice. The extract demonstrated significant improvements in behavioral assays such as the Morris Water Maze and Elevated Plus Maze, alongside biochemical evidence of acetylcholinesterase inhibition, reduced oxidative stress, and improved neuronal integrity. The bioactive compounds such as embelin, flavonoids, and polyphenols play a pivotal role in these neuroprotective effects. This review highlights the therapeutic promise of E. Ribes as a nootropic agent and advocates for further pharmacokinetic and clinical validation